# Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy

> **NCT04082520** · PHASE2 · RECRUITING · sponsor: **Mayo Clinic** · enrollment: 42 (estimated)

## Conditions studied

- Grade 1 Meningioma
- Grade 2 Meningioma
- Grade 3 Meningioma
- Recurrent Meningioma
- Unresectable Meningioma

## Interventions

- **RADIATION:** Gallium Ga 68-DOTATATE
- **DRUG:** Lutetium Lu 177 Dotatate
- **PROCEDURE:** Magnetic Resonance Imaging
- **PROCEDURE:** Positron Emission Tomography
- **OTHER:** Questionnaire Administration
- **PROCEDURE:** Computed Tomography
- **PROCEDURE:** Biospecimen Collection
- **PROCEDURE:** Single Photon Emission Computed Tomography

## Key facts

- **NCT ID:** NCT04082520
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-04-14
- **Primary completion:** 2027-09-04
- **Final completion:** 2032-03-04
- **Target enrollment:** 42 (ESTIMATED)
- **Last updated:** 2026-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04082520

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04082520, "Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy". Retrieved via MORVS 2026-10-10 from https://api.morvs.ai/clinical/NCT04082520. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*